Journal for ImmunoTherapy of Cancer
Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 136. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 4,22 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 4,22.
Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, tumor, t, society, patient, therapy, cell, carcinoma, ...
Unclaimed profile — some fields may be incomplete.
Metrics
Campos Scimago / CoP — sin series inventadas
SJR Impact
4,22
H-index
136
Docs (year)
471
Docs 3y
1524
Total refs
20875
Cites 3y
14439
Citable 3y
1494
Cites/Doc 2y
9.1
Ref/Doc
44.32
Immediate OA
1694 €
Embargoed OA
NPD
Non OA / Submission
- €
Name good journals. Call out predatory ones.
Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.